226 related articles for article (PubMed ID: 31830053)
21. Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group.
D'Angiò M; Valsecchi MG; Testi AM; Conter V; Nunes V; Parasole R; Colombini A; Santoro N; Varotto S; Caniglia M; Silvestri D; Consarino C; Levati L; Magrin E; Locatelli F; Basso G; Foà R; Biondi A; Cazzaniga G
Haematologica; 2015 Jan; 100(1):e10-3. PubMed ID: 25304610
[No Abstract] [Full Text] [Related]
22. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.
Schrappe M; Valsecchi MG; Bartram CR; Schrauder A; Panzer-Grümayer R; Möricke A; Parasole R; Zimmermann M; Dworzak M; Buldini B; Reiter A; Basso G; Klingebiel T; Messina C; Ratei R; Cazzaniga G; Koehler R; Locatelli F; Schäfer BW; Aricò M; Welte K; van Dongen JJ; Gadner H; Biondi A; Conter V
Blood; 2011 Aug; 118(8):2077-84. PubMed ID: 21719599
[TBL] [Abstract][Full Text] [Related]
23. Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.
Modvig S; Madsen HO; Siitonen SM; Rosthøj S; Tierens A; Juvonen V; Osnes LTN; Vålerhaugen H; Hultdin M; Thörn I; Matuzeviciene R; Stoskus M; Marincevic M; Fogelstrand L; Lilleorg A; Toft N; Jónsson OG; Pruunsild K; Vaitkeviciene G; Vettenranta K; Lund B; Abrahamsson J; Schmiegelow K; Marquart HV
Leukemia; 2019 Jun; 33(6):1324-1336. PubMed ID: 30552401
[TBL] [Abstract][Full Text] [Related]
24. Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.
Russell LJ; Jones L; Enshaei A; Tonin S; Ryan SL; Eswaran J; Nakjang S; Papaemmanuil E; Tubio JM; Fielding AK; Vora A; Campbell PJ; Moorman AV; Harrison CJ
Genes Chromosomes Cancer; 2017 May; 56(5):363-372. PubMed ID: 28033648
[TBL] [Abstract][Full Text] [Related]
25. Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups.
Attarbaschi A; Morak M; Cario G; Cazzaniga G; Ensor HM; te Kronnie T; Bradtke J; Mann G; Vendramini E; Palmi C; Schwab C; Russell LJ; Schrappe M; Conter V; Mitchell CD; Strehl S; Zimmermann M; Pötschger U; Harrison CJ; Stanulla M; Panzer-Grümayer R; Haas OA; Moorman AV;
Br J Haematol; 2012 Sep; 158(6):772-7. PubMed ID: 22816614
[TBL] [Abstract][Full Text] [Related]
26. [Outcome of childhood T-cell acute lymphoblastic leukemia: a report of 99 cases].
Cai JY; Xue HL; Chen J; Shen SH; Pan C; Wang X; Zhou M; Tang YJ; Gao YJ; Wang JM; Tang JY
Zhonghua Er Ke Za Zhi; 2016 Jun; 54(6):456-60. PubMed ID: 27256235
[TBL] [Abstract][Full Text] [Related]
27. CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities.
Chiaretti S; Brugnoletti F; Messina M; Paoloni F; Fedullo AL; Piciocchi A; Elia L; Vitale A; Mauro E; Ferrara F; De Fabritiis P; Luppi M; Ronco F; De Propris MS; Raponi S; Kronnie GT; Vignetti M; Guarini A; Foà R
Leuk Res; 2016 Feb; 41():36-42. PubMed ID: 26754556
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcome of childhood lymphoblastic lymphoma in Shanghai China 2001-2010.
Gao YJ; Pan C; Tang JY; Lu FJ; Chen J; Xue HL; Zhai XW; Li J; Ye QD; Zhou M; Wang HS; Miao H; Qian XW; Xu Z; Meng JH
Pediatr Blood Cancer; 2014 Apr; 61(4):659-63. PubMed ID: 24243691
[TBL] [Abstract][Full Text] [Related]
29. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.
Virk H; Rana S; Sharma P; Bose PL; Yadav DD; Sachdeva MUS; Varma N; Trehan A; Lad D; Khadwal AR; Malhotra P; Sreedharanunni S
Ann Hematol; 2021 Aug; 100(8):2031-2041. PubMed ID: 34159401
[TBL] [Abstract][Full Text] [Related]
30. Potential efficacy and prognosis of silencing the CRLF2‑mediated AKT/mTOR pathway in pediatric acute B‑cell lymphoblastic leukemia.
Jiang M; Zou X; Lu L
Oncol Rep; 2019 Feb; 41(2):885-894. PubMed ID: 30535452
[TBL] [Abstract][Full Text] [Related]
31. GATA3 germline variant is associated with CRLF2 expression and predicts outcome in pediatric B-cell precursor acute lymphoblastic leukemia.
Madzio J; Pastorczak A; Sedek L; Braun M; Taha J; Wypyszczak K; Trelinska J; Lejman M; Muszynska-Roslan K; Tomasik B; Derwich K; Koltan A; Kazanowska B; Irga-Jaworska N; Badowska W; Matysiak M; Kowalczyk J; Styczynski J; Fendler W; Szczepanski T; Mlynarski W
Genes Chromosomes Cancer; 2019 Sep; 58(9):619-626. PubMed ID: 30859636
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of TLE1 Gene Expression in Patients with T-cell Acute Lymphoblastic Leukemia.
Aref S; El-Ghonemy MS; Atia DM; Elbaiomy MM; Abdelsalam SA; Tawfik A; El-Sebaie A
Asian Pac J Cancer Prev; 2021 May; 22(5):1653-1658. PubMed ID: 34048198
[TBL] [Abstract][Full Text] [Related]
33. Combined analysis of
Cui L; Gao C; Wang CJ; Zhao XX; Li WJ; Li ZG; Zheng HY; Wang TY; Zhang RD
Leuk Lymphoma; 2021 Feb; 62(2):410-418. PubMed ID: 33054468
[TBL] [Abstract][Full Text] [Related]
34. CRLF2 overexpression defines an immature-like subgroup which is rescued through restoration of the PRC2 function in T-cell precursor acute lymphoblastic leukemia.
Maciel ALT; Wolch K; Emerenciano M; Mansur MB
Genes Chromosomes Cancer; 2022 Jul; 61(7):437-442. PubMed ID: 35253299
[TBL] [Abstract][Full Text] [Related]
35. [Expression of
Wu SY; Chu XR; Ji Q; Lin XC; Bai ZJ; Li JQ; Pan J; Chen ZX; Hu SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):999-1004. PubMed ID: 37551468
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of cytokine receptor-like factor 2 alterations in acute lymphoblastic leukemia: a meta-analysis.
Jia M; Wang ZJ; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Tang YM
World J Pediatr; 2015 May; 11(2):126-33. PubMed ID: 25920591
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of CRLF2 overexpression and JAK2 mutation in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia.
Hassan NM; Abdellateif MS; Radwan EM; Hameed SA; Desouky EDE; Kamel MM; Gameel AM
Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):e376-e385. PubMed ID: 34987014
[TBL] [Abstract][Full Text] [Related]
38. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.
Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S
Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346
[TBL] [Abstract][Full Text] [Related]
39. [Clinical pathologic characteristics and treatment outcomes of 19 relapsed pediatric B-cell lymphoma].
Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Ma XL; Zhang YH
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):748-753. PubMed ID: 29050112
[No Abstract] [Full Text] [Related]
40. MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.
Hayashi RJ; Hermiston ML; Wood BL; Teachey DT; Devidas M; Chen Z; Annett RD; Asselin BL; August K; Cho S; Dunsmore KP; Freedman JL; Galardy PJ; Harker-Murray P; Horton TM; Jaju A; Lam A; Messinger YH; Miles RR; Okada M; Patel S; Schafer ES; Schechter T; Shimano KA; Singh N; Steele A; Sulis ML; Vargas SL; Winter SS; Wood C; Zweidler-McKay PA; Loh ML; Hunger SP; Raetz EA; Bollard CM; Allen CE
Blood; 2024 May; 143(20):2053-2058. PubMed ID: 38457359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
